维普期刊资源整合服务平台（V6.5）

121篇 您的检索式：作者名="CALIGIURI MA"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Biology of human natural killer cell subsets 显示文摘	Cooper MA Fehniger TA Caligiuri MA	2001	Trends Immunol2001，22，5：	2
2	The biology of human natural killer- cell subsets显示文摘	Cooper MA Fehniger TA Caligiuri MA	2001	Trends Immunol2001，22，11：	1
3	Human natural killer cells显示文摘	CALIGIURI MA	2008	Blood2008，112，3：	1
4	The biology of human natural killer-cell subsets 显示文摘	Cooper MA Fehniger TA Caligiuri MA	2001	Trends Immunol2001，22，11：	1
5	What does it take to makea natural killer显示文摘	Colucci F Caligiuri MA Di Santo JP	2003	Nat Rev Immunol2003，3，5：	1
6	Biology of human natural killer cell subsets显示文摘	Cooper MA Fehniger TA Caligiuri MA	2001	Trends Immunol2001，22，2：	1
7	Interleukin 15:biology and relevance to human disease显示文摘	Fehniger TA Caligiuri MA	2001	Blood2001，97，1：	1
8	Human natural killer cells 显示文摘	Caligiuri MA	2008	Blood2008，112，3：	1
9	Human natural killer cell development and biology显示文摘	Farag SS Caligiuri MA	2006	Blood Rev2006，20，3：	1
10	Molecular and clinical advances in core binding factor primary acute myeloid leukemia: a paradigm for translational research in malignant hematology显示文摘	Marcucci G Caligiuri MA Bloomfield CD	2000	Cancer Invest2000，18，8：	1
11	Loe-dose interleukin-2 im- munotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission:Cancer and leukemia group B study 9720显示文摘	Mer MR George SL Caligiuri MA	2008	J Clin Oncol2008，26，30：	1
12	Rituximab: Converging mechanisms of action in non-Hodgkin' s lymphoma? 显示文摘	Eisenbeis CF Caligiuri MA Byrd JC	2003	Clin Cancer Res2003，9，161：	1
13	Interleukin-2 and interleukin-15:immunotherapy for cancer显示文摘	Fehniger TA Cooper MA Caligiuri MA	2002	Cytokine Growth Factor Rev2002，13，2：	1
14	The biology of human natural killer-cell subsets显示文摘	Cooper MA Fehniger TA Caligiuri MA	2001	Trends Immunol2001，22，11：	1
15	The biology of human natural killer-cell subsets显示文摘	Cooper MA Fehniger TA Caligiuri MA		0，，：	1
16	Rearrangement of ALL1(MLL)in acute myeloid leukemia with normal cytogenetics显示文摘	Caligiuri MA Strout MP Lawrence D	1998	Cancer Res1998，58，1：	1
17	The biology of human naturalkiller2cell subsets 显示文摘	Cooper MA Fehniger TA Caligiuri MA	2001	Trends Immunol2001，22，11：	1
18	Low-dose Interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720 显示文摘	Baer MR George SL Caligiuri MA	2008	J Clin Oncol2008，26，30：	1
19	The biology of human natural killer-cell subsets 显示文摘	Cooper MA Fehniger TA Caligiuri MA	2001	Trends Immunol2001，22，11：	1
20	Molecular biology of acute myeloid leukemia显示文摘	Caligiuri MA Strout MP Gilliland DG	1997	Semin Oncol1997，24，1：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示